Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, et al. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am J Transplant. 2017;17(1):28-41.

Ebot EM, Gerke T, Labbé DP, Sinnott JA, Zadra G, Rider JR, et al. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. Cancer. 2017;123(21):4130-4138.

Aukes K, Forsman C, Brady NJ, Astleford K, Blixt N, Sachdev D, et al. Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions. PLoS One. 2017;12(10):e0185736.

Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, et al. Personalized and Cancer Models to Guide Precision Medicine. Cancer Discov. 2017;7(5):462-477.

Jia L, Yan F, Cao W, Chen Z, Zheng H, Li H, et al. Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. J Biol Chem. 2017;292(7):2966-2978.

Prandi D, Baca SC, Romanel A, Barbieri CE, Mosquera J-, Fontugne J, et al. Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations. Genome Biol. 2017;18(1):80.

Romanel A, Garritano S, Stringa B, Blattner M, Dalfovo D, Chakravarty D, et al. Inherited determinants of early recurrent somatic mutations in prostate cancer. Nat Commun. 2017;8(1):48.

Marchionni L, Hayashi M, Guida E, Ooki A, Munari E, Jabboure FJ, et al. MicroRNA expression profiling of Xp11 renal cell carcinoma. Hum Pathol. 2017;67:18-29.

Magro CM, Momtahen S. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma. Am J Dermatopathol. 2017;39(2):95-103.

Levin LE, Magro C, Horowitz J, Harp J. Hydralazine-associated cutaneous casculitis presenting with aerodigestive tract involvement. Cutis. 2017;99(5):E25-E29.